RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 76 filers reported holding RA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,483,000 | -23.7% | 1,373,524 | -3.0% | 0.18% | -24.2% |
| Q2 2019 | $42,594,000 | +34.2% | 1,416,524 | 0.0% | 0.24% | +29.0% |
| Q1 2019 | $31,730,000 | +19.9% | 1,416,524 | -2.6% | 0.18% | +10.9% |
| Q4 2018 | $26,457,000 | +36.2% | 1,453,724 | +35.4% | 0.16% | +58.7% |
| Q3 2018 | $19,426,000 | +151.1% | 1,073,906 | +38.1% | 0.10% | +131.1% |
| Q2 2018 | $7,735,000 | +154600.0% | 777,487 | +69629.8% | 0.04% | – |
| Q1 2018 | $5,000 | – | 1,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |